A

AgenT

120 employees

AgenT develops the first blood diagnosis to detect Alzheimer's disease from the asymptomatic stage.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Machine learning
Life Science
Neuroscience
Diagnosis
AI
ALzheimer's disease
Health Diagnostics
Health Care

Date founded

2018

Funding rounds raised

A

AgenT raised undisclosed on January 1, 2021

Investors: Creative Destruction Lab

FAQ